Unraveling the Mysteries of Protein Folding and Misfolding

被引:55
作者
Ecroyd, Heath [1 ]
Carver, John A. [1 ]
机构
[1] Univ Adelaide, Sch Chem & Phys, Adelaide, SA 5005, Australia
基金
英国医学研究理事会; 澳大利亚研究理事会;
关键词
protein folding; protein misfolding; protein aggregation; amyloid; fibril; small heat shock protein; Alzheimer's disease; Parkinson's disease;
D O I
10.1002/iub.117
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
This mini-review focuses on the processes and consequences of protein folding and misfolding. The latter process often leads to protein aggregation and precipitation with the aggregates adopting either highly ordered (amyloid fibril) or disordered (amorphous) forms. In particular, the amyloid fibril is discussed because this form has gained considerable notoriety due to its close links to a variety of debilitating diseases including Alzheimer's, Parkinson's, Huntington's, and Creutzfeldt-Jakob diseases, and type-II diabetes. In each of these diseases a different protein forms fibrils, yet the fibrils formed have a very similar structure. The mechanism by which fibrils form, fibril structure, and the cytotoxicity associated with fibril formation are discussed. The generic nature of amyloid fibril structure suggests that a common target may be accessible to treat amyloid fibril-associated diseases. As such, the ability of some molecules, for example, the small heat-shock family of molecular chaperone proteins, to inhibit fibril formation is of interest due to their therapeutic potential. (C) 2008 IUBMB
引用
收藏
页码:769 / 774
页数:6
相关论文
共 32 条
[1]
PRINCIPLES THAT GOVERN FOLDING OF PROTEIN CHAINS [J].
ANFINSEN, CB .
SCIENCE, 1973, 181 (4096) :223-230
[2]
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases [J].
Bucciantini, M ;
Giannoni, E ;
Chiti, F ;
Baroni, F ;
Formigli, L ;
Zurdo, JS ;
Taddei, N ;
Ramponi, G ;
Dobson, CM ;
Stefani, M .
NATURE, 2002, 416 (6880) :507-511
[3]
Small heat-shock proteins and clusterin: Intra- and extracellular molecular chaperones with a common mechanism of action and function? [J].
Carver, JA ;
Rekas, A ;
Thorn, DC ;
Wilson, MR .
IUBMB LIFE, 2003, 55 (12) :661-668
[4]
Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders [J].
Caughey, B ;
Lansbury, PT .
ANNUAL REVIEW OF NEUROSCIENCE, 2003, 26 :267-298
[5]
Rationalization of the effects of mutations on peptide and protein aggregation rates [J].
Chiti, F ;
Stefani, M ;
Taddei, N ;
Ramponi, G ;
Dobson, CM .
NATURE, 2003, 424 (6950) :805-808
[6]
Designing conditions for in vitro formation of amyloid protofilaments and fibrils [J].
Chiti, F ;
Webster, P ;
Taddei, N ;
Clark, A ;
Stefani, M ;
Ramponi, G ;
Dobson, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) :3590-3594
[7]
Protein misfolding, functional amyloid, and human disease [J].
Chiti, Fabrizio ;
Dobson, Christopher M. .
ANNUAL REVIEW OF BIOCHEMISTRY, 2006, 75 :333-366
[8]
Sequence determinants of amyloid fibril formation [J].
de la Paz, ML ;
Serrano, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (01) :87-92
[9]
Experimental investigation of protein folding and misfolding [J].
Dobson, CM .
METHODS, 2004, 34 (01) :4-14
[10]
Protein misfolding, evolution and disease [J].
Dobson, CM .
TRENDS IN BIOCHEMICAL SCIENCES, 1999, 24 (09) :329-332